Xenios AG
  • ECLS with XENIOS 2.0
  • Therapeutic Applications
  • Heart & Lung Campus
  • About us
  • EN
  • DE
  • ECLS with XENIOS 2.0
    • Back
    • Overview ECLS with XENIOS 2.0
    • Patient kits
    • MultiSupport GROUND transport solution
  • Therapeutic Applications
    • Back
    • Overview of therapeutic applications
    • ECLS treatment options
      • Back
      • Overview of ECLS treatment options
      • ECMO
      • Pediatric ECMO
      • Synchronized cardiac support
      • ECCO2R
    • Cannulation
    • Indications
      • Back
      • Indications overview
      • Acute respiratory distress syndrome (ARDS)
      • Cardiogenic shock (CS)
      • Chronic obstructive pulmonary disease (COPD)
  • Heart & Lung Campus
  • About us
    • Back
    • About us – Who we are
    • Career
    • Company profile
    • Service & Contact
    • Media Center
    • News & Events
    • Newsletter
    • IFU
    • SVHC
  • Contact
  • Newsletter
Loading Events

« All Events

ESPNIC 2025

25. June 2025 - 28. June 2025

  • « EuroPCR 2025
  • EACTS 2025 »

The Paediatric and Neonatal Intensive Care Congress brings PICU & NICU teams together

  • Google Calendar
  • iCalendar
  • Outlook 365
  • Outlook Live

Details

Start:
25. June 2025
End:
28. June 2025
Website:
https://www.mcascientificevents.eu/espnic/

Venue

Auditorio de la diputación de Alicante, Spain
  • « EuroPCR 2025
  • EACTS 2025 »

Events contact

kongresse@xenios-ag.com

A Fresenius Medical Care company
End of 2016, Xenios became a part of Fresenius Medical Care, the world’s leading provider of products and services for people with chronic kidney failure.
www.freseniusmedicalcare.com

Notice
Not all products and services are cleared or available for sale in all countries.

Please check your country-specific regulations.

Find us on

  • Youtube
  • LinkedIn
  • Twitter

Partner

  • Legal notice
  • Terms and conditions
  • Privacy policy
  • SVHC
  • IFU
Info

Not all products or services presented on this website are cleared or available for sale in all countries. For further information on country-specific regulations, please contact your local Xenios AG representative.

Also, the information on this website is not intended for an audience within the USA. If your are from the USA, please visit the corresponding Fresenius Medical Care website here

Accepted and Confirmed